Swiss Association for Ketogenic Metabolic Therapies

Concerns about low-carb diets and kidney health often arise from fears about high protein consumption. However, research does not support the idea that a whole-food, high-protein diet damages kidney function. In fact, poor metabolic health is likely a much more significant risk factor for kidney dysfunction. Emerging evidence suggests that metabolic therapies, like low-carb diets, may actually improve kidney function, particularly for those with type 2 diabetes. In this study, patients who followed a low-carb diet saw positive changes in kidney markers, likely due to improved metabolic factors, such as better glucose control, reduced blood pressure, and lower triglyceride levels. Curious to learn more? Dr. Bret Scher breaks down the science behind low-carb and ketogenic diets and kidney health in our video: 👉 https://lnkd.in/g-RGf9Vj Study Link: https://lnkd.in/gWci_QBM

Very-low-carbohydrate ketogenic diets, originally used in pediatric epilepsy, are now being recognized for their potential to treat other conditions, including mental health disorders and chronic kidney disease. The carnivore diet has received growing anecdotal support for improving various health issues. A recent case series explored the effects of animal-based ketogenic diets and carnivore diets in 10 patients living with Crohn’s disease or ulcerative colitis, the two forms of inflammatory bowel disease (IBD). These patients, who had not achieved remission with conventional treatments, experienced several beneficial changes after following these dietary approaches for periods ranging from five months to five years: 🔷All 10 patients reported significant symptom relief and achieved clinical remission (based on Inflammatory Bowel Disease Questionnaire scores). 🔷Patients had improvements in biomarkers, including dramatic reductions in calprotectin, an indicator of intestinal inflammation. 🔷Most patients were able to discontinue medications, maintaining remission through diet alone. 🔷Weight loss (in patients with overweight or obesity) and improved energy levels were common among the patients. 🔷Patients reported that their diets were enjoyable, easy to sustain, and profoundly enhanced their quality of life. 🔷The diets proved effective in cases where standard treatments had failed. The efficacy of these dietary approaches is thought to stem from carbohydrate reduction, elimination of immune triggers, the anti-inflammatory effects of ketosis, and the beneficial impacts of ketogenic and low-fiber diets on the gut microbiome. This case series highlights the potential of ketogenic and carnivore diets as therapeutic options for IBD. However, the authors acknowledge the need for further research to validate these findings and assess long-term safety. Future studies should compare these diets with other therapeutic approaches to better understand their benefits and risks in managing IBD. — Nick Norwitz, Adrian Soto Mota. Case report: Carnivore–ketogenic diet for the treatment of inflammatory bowel disease: a case series of 10 patients. Front. Nutr. 2024 Sep; 11 https://lnkd.in/gVhM_JWS 📌 Link to study: https://lnkd.in/gVhM_JWS 📌 Find more research summaries on our website: https://lnkd.in/gKeXEcEN #Keto #Carnivorediet #IBD #Research #Crohns #UlcerativeColitis #GutHealth

Rescheduled for July 23rd at 10am PT. Register below 💥 ! Join us for an intimate Live Q&A with Dr. Elena Gross on the metabolic management of migraines! This Live Q&A will be hosted by Victoria Field and Dr. Dominic D'Agostino and will take place inside our CME-centered medical education platform, The Metabolic Initiative, on July 15th at 10am PT/1pm ET. Dr. Elena Gross is a neuroscientist with a PhD in Clinical Research and a former chronic migraine sufferer. Her personal experience with the condition motivated her to pursue an MSc in Neuroscience at the University of Oxford and a PhD at the University of Basel, where she focused on understanding and improving treatments for migraine. Her research interests include the therapeutic potential of ketosis and nutritional interventions, the impact of mitochondrial functioning on brain health, and the prevention of neurological diseases. Dr. Gross is particularly passionate about extending health spans through innovative approaches to disease prevention. Dr. Gross is a pioneer in the metabolic management of migraines, exploring how ketogenic diets and other metabolic therapies can alleviate migraine symptoms. She investigates how altering energy metabolism in the brain can reduce the frequency and severity of migraine attacks, offering new hope for patients who have not found relief with traditional treatments. As the founder and CEO of KetoSwiss and MigraKet, Dr. Gross also has invented several patents and successfully translated her research into practical solutions. Bring your questions for Dr. Elena Gross and join the Q&A for FREE when you sign up for a 7-day trial to The Metabolic Initiative at https://lnkd.in/g9fqfJxY Your membership also includes access to 100+ video lectures on metabolic therapy, private episodes of our podcast The Metabolic Link, and comprehensive research reviews detailing the latest findings in metabolic health!

New Blog - https://lnkd.in/dQEbHq5J

'People who thought that cigarettes cause cancer weren’t wrong, just 21st century cigarettes=the average American diet. Just as we rallied against the dangers of smoking, it’s time to wage war on the ultra-processed foods that have silently infiltrated our diets.' -Grace Price